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Abstract
We have previously shown that soluble factors
derived from mesenchymal stem cells (MSCs) induce
oligodendrogenic fate and differentiation in adult rat
neural progenitors (NPCs) in vitro. Here, we
investigated if this pro-oligodendrogenic effect is
maintained after cells have been transplanted onto
rat hippocampal slice cultures, a CNS-organotypic
environment. We first tested whether NPCs, that were
pre-differentiated in vitro by MSC-derived conditioned
medium, would generate oligodendrocytes after
transplantation. This approach resulted in the loss of
grafted NPCs, suggesting that oligodendroglial
pre-differentiated cells could not integrate in the tissue
and therefore did not survive grafting. However, when
NPCs together with MSCs were transplanted in situ
into hippocampal slice cultures, the grafted NPCs
survived and the majority of them differentiated into
oligodendrocytes. In contrast to the prevalent
oligodendroglial differentiation in case of the
NPC/MSC co-transplantation, naïve NPCs
transplanted in the absence of MSCs differentiated
predominantly into astrocytes. In summary, the
pro-oligodendrogenic activity of MSCs was
maintained only after co-transplantation into
hippocampal slice cultures. Therefore, in the
otherwise astrogenic milieu, MSCs established an
oligodendrogenic niche for transplanted NPCs, and
thus, co-transplantation of MSCs with NPCs might
provide an attractive approach to re-myelinate the
various regions of the diseased CNS.
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Introduction
Oligodendrocytes are the desired cell types for any
cell replacement approach in several pathological
conditions characterized by myelin loss in the central
nervous system (CNS), such as in multiple sclerosis (MS),
spinal cord injury (SCI) or multi-system atrophy (MSA).
In vivo, oligodendroglial progenitors, which are present
in the CNS parenchyma, have the capacity to generate
oligodendrocytes and re-myelinate axons (for review see
[1]). Indeed, in some pathologies including subsets of MS,
successful re-myelination is a key event in the course of
functional recovery [2]. Conversely, in other subsets of
MS and after SCI the occurrence of re-myelination is
highly limited [3-5]. In the latter cases, ex vivo generation
and transplantation of cells with an oligodendrogenic
potential constitutes an attractive alternative strategy to
promote re-myelination. This might be achieved by the
use of neural stem and progenitor cells (NPCs) that can
be harvested from the adult CNS and expanded in cell
culture [6, 7].
We have recently demonstrated that MSCs and
soluble factors secreted by MSCs robustly induced and
promoted the oligodendroglial fate and concomitantly
inhibited the astroglial fate of adult rat NPCs in vitro [8,
9]. Indeed, the co-cultivation of NPCs with MSCs is to
our knowledge the most efficient method to differentiate
adult NPCs into oligodendrocytes without genetic
manipulation [8].
Here, we investigated if the oligodendroglial activity
of MSCs on NPCs is maintained after co-transplantation
of MSCs/NPCs into a CNS-organotypic environment.
Hippocampal slice cultures were used as a target tissue,
since i) they are well established and widely used as CNS
organotypic cultures containing several well-described
nerve fibers [10], and ii) they preserve regions of
neurogenic activity and demonstrate neural progenitor
proliferation and differentiation [11]. Hence, hippocampal
slice cultures served as a host tissue for MSC / NPC
transplantation and survival and differentiation of the
transplanted NPCs were investigated.
Materials and Methods
Animal subjects
Adult female Fischer 344 rats (Charles River Deutschland
GmbH, Germany) weighing 160-180g were used as donors for
the isolation of MSCs and NPCs. Nineteen to 21 days postnatal
Wistar rats were used as donors for the hippocampal slice
cultures. All experiments were carried out in accordance with
the European Communities Council Directive (86/609/EEC) and
institutional guidelines. Animals had ad libitum access to food
and water throughout the study.
MSC and NPC cultures
NPCs derived from the adult hippocampus and
subventricular zone were generated as described [7, 8]. Briefly,
five 2 to 4 month-old female Fischer-344 rats (Charles River
Deutschland GmbH, Germany) were decapitated. Hippocampi
were aseptically removed, transferred to 4°C DPBS (PAN,
Germany) with 4.5g/L glucose (Merck, Germany) (DPBS/glu),
washed once, transferred to petri dishes and dissociated
mechanically. The cell suspension was washed in DPBS/glu
and resuspended in PPD-solution containing 0.01% Papain
(Worthington Biochemicals, England), 0.1% dispase II
(Boehringer, Germany), 0.01% DNase I (Worthington
Biochemicals, England) and 12.4 mM MgSO4 in HBSS (PAN,
Germany) without Mg++/Ca++ (PAA, Germany) and digested for
30 to 40 min at 37°C. The cell suspension was triturated every
10 min. Dissociated cells were collected and resuspended in
Neurobasal (NB) medium containing B27 (Gibco BRL, Germany),
2mM L-glutamine and 100U/mL penicillin/ 100 µg/ml
streptomycin and washed three times. Finally, the single cell
suspension was resuspended in NB medium (Gibco BRL,
Germany) supplemented with B27 (Gibco BRL, Germany) (NB/
B27), 2 mM L-glutamine (PAN, Germany), 100U/mL penicillin/
100 µg/ml streptomycin (PAN, Germany), 2 µg/ml heparin
(Sigma, Germany), 20 ng/ml bFGF-2 (R&D Systems, Germany)
and 20 ng/ml EGF (R&D Systems, Germany). Cultures were
maintained at 37°C in an incubator with 5% CO
2
. Half of the
medium was changed every 7 days. Neurosphere cultures from
passage number 2 to 6 were used throughout this study.
MSCs were prepared as described previously [8]. Briefly,
bone marrow plugs were harvested from femurs and tibias of 2-
4 month-old female Fisher-344 rats (Charles River Deutschland
GmbH, Germany). Plugs were mechanically dissociated in
DMEM and recovered by centrifugation. Cell pellets were
resuspended in DMEM-10% fetal bovine serum (FBS) and
seeded at 1x106 cells/cm2. After 3 days, media was changed and
non-adherent cells were removed. Adherent cells were
incubated in fresh DMEM-10% FBS until a confluent layer of
cells was achieved. Cells were trypsinized using 0.25% Trypsin
(Gibco Cell Culture, Invitrogen GmbH, Germany) and seeded in
DMEM-10% FBS at 8,000 cells/cm2. After 3-5 days of culture,
the resulting monolayer of cells, hereafter named rat bone
marrow-derived mesenchymal stem cells (MSCs), was
trypsinized and further cultured for experiments or frozen for
later use. As demonstrated in our previous work, this cell culture
preparation is highly enriched in multipotent MSCs with virtually
no hematopoietic contamination [8].
Labeling of cells
NPCs were incubated with 1 µM 5-bromo-2´-deoxyuridine
(BrdU, Sigma, Germany) in growth medium for 48 h before
transplantation. BrdU-incorporation could be demonstrated in
more than 95% of NPCs by immunohistochemistry (data not
shown). EGFP-labeled MSCs were used in the hippocampal
slice culture transplantation experiments. To this end, we used
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an HIV-based lentiviral eGFP vector pseudotyped with VSVG,
where eGFP is encoded under the control of the human ubiquitin
C promotor [12]. A total of 107 MSCs were transduced in 0.5 ml
of medium with 107 infectious viral particles for 1,5 hrs at 37°C,
washed and seeded. Two days later, the eGFP expressing cells
are enriched to approximately 90% by FACS sorting using a
FACSAria (Becton Dickinson).
NPC pre-differentiation
NPCs were pre-differentiated by the MSCs-derived
conditioned medium (MSC-CM). MSC-CM was prepared as
described [8]. Briefly, MSCs were plated at 12,000 cells/cm2 and
incubated in DMEM-10% FBS. After 3 days, the conditioned
medium was collected and filtered using a 0.22 Pm-pore filter.
BrdU-labeled NPCs were plated on polyornithine (100µg/ml)
and laminin (5µg/ml)-coated dishes and incubated for 2 days
with MSC-CM. After this period, cells were treated with 0.25%
trypsin (Gibco BRL, Germany) and collected for transplantation
(Fig. 1 A). Based on our previous studies, this time frame is
sufficient to trigger an oligodendrogenic program in NPCs, since
i) the presence of MSC-CM for two to three days was sufficient
to increase the expression level of pro-oligodendrogenic
transcription factors (olig 1/2) and to decrease expression level
of the anti- oligodendrogenic factor Id2 [8], and ii) a two day
incubation with MSC-CM was sufficient to induce and promote
the expression of the oligodendroglial markers GalC and MBP
and to inhibit expression of the astroglial marker GFAP [9].
Organotypic hippocampal slice cultures and cell
transplantation
Preparation and maintenance of organotypic hippocampal
slice cultures and cell transplantation were performed as
described [10]. Briefly, postnatal day 19-21 Wistar rats were
decapitated, the brains removed and placed into ice-cold
preparation medium. Horizontal 350 µm sections were prepared
on a Leica VT-1000 vibratome (Leica Microsystems, Bensheim,
Germany), placed in transwell cell-culture inserts in 6 well plates
(Greiner Bioscience, Germany) and cultured as interface cultures
[13] in slice culture medium [14]. The slices were cultured in a
humidified atmosphere at 35°C. Medium was changed on the
first day and every other day thereafter. For stem cell
transplantation, a total of 5,000 cells (MSCs, NPCs or a 1:1 mix
of both, Fig.1 B) were grafted one day after slice culture
preparation into different hippocampal regions (CA region and
dentate gyrus) in 0.05 µl of medium using a Hamilton syringe.
Alternatively, 5,000 MSC-CM pre-conditioned (pre-
differentiated) BrdU-labeled NPCs were transplanted (Fig. 1
A). After 7 days, slices were fixed in 4 % paraformaldehyde for
24 hours and placed in 30% sucrose.
Immunohistology
Immunostaining and histological analysis was performed
with free-floating sections to assess the NPCs differentiation
pattern in vivo. To visualize the transplanted BrdU-labeled
NPCs, the hippocampal slices were washed 3 times with TBS
and incubated for 1h in 50% formamide/2xSSC (0.3M NaCl,
0.03M sodium citrate) at 65°C. Sections were rinsed in 2xSSC,
incubated for 30 min in 2M HCl at 37°C and rinsed for 10 min on
0.1M boric acid (pH 8.5). After rinsing in Tris-buffered saline
(TBS), sections were blocked in TBS + 3% donkey serum +
0.1% Triton-X100 for 1h. The same solution was used for the
antibody solution. Primary antibodies were applied overnight
at 4°C. Fluorochrome-conjugated species-specific secondary
antibodies were used for immunodetection. The following
primary antibodies were used: rat anti-BrdU for grafted NPC
1:500 (AbDSerotec, UK), rabbit anti-GFAP for astroglia 1:1000
(Dako, Denmark A/S, Glostrup, Denmark), mouse anti-Myelin
Basic Protein (MBP) for oligodendrocytes 1:750 (SMI-94,
Sternberger Monoclonals Inc., U.S.A.), rabbit anti-glutathione
S-Transferase placental form (GST-pi) for oligodendrocytes
1:2000 (Biomol, Germany), rabbit anti-green fluorescence
protein (GFP) 1:500 for the detection of transplanted GFP-
expressing MSCs (Rockland, Gilbertsville, USA), rabbit anti-
active caspase-3 1:100 for the detection of cells undergoing
apoptosis (Promega, Madison, Wisconsin, USA), rabbit anti-
Iba1 1:500 for the detection of microglia (Wako Chemicals GmbH,
Neuss, Germany). Secondary antibodies: donkey anti-mouse,
rabbit conjugated with Alexa Fluor© 488 1:1000 (Molecular
Probes, U.S.A.), rhodamine X (RHOX) 1:1000 (Dianova,
Germany) or Cy5 1:500 (Dianova, Germany). Specimens were
mounted on microscope slides using Prolong Gold Antifade kit
(Invitrogen GmbH, Karlsruhe, Germany).
Quantitative Analysis
Transplanted BrdU-labeled NPCs in hippocampal slice
cultures were visualized using a Leica microscope (Leica
Mikroskopie und Systeme GmbH, Germany) equipped with a
Spot™ digital camera (Diagnostic Instrument Inc, U.S.A.) at
200 x or 400 x magnification. Cell survival was determined as
percentage of the total BrdU-positive cells found in respect to
the total NPCs transplanted. The fate of BrdU-labeled NPCs
was analyzed by double-immunofluorescence staining for BrdU
and cell-type specific markers and confocal fluorescence
microscopy (Leica TCS-NT). For each condition, 3 to 5 randomly
selected observation fields, containing in total 150-400 cells,
were analyzed in the z-axis and photographed. Three
independent experiments were analyzed.
Statistical Analysis
Statistical analysis was performed for all experiments using
non-parametrical one-tailed Mann Whitney t test. Averages
are expressed with their standard deviations. Statistical analysis
was performed using PRISM 4 software.
Results
The present work investigates the potency of
MSC-derived signals to increase the oligodendroglial
differentiation capacity of transplanted NPCs.
Two different experimental designs were tested: i) NPCs
were first pre-conditioned with MSC-derived conditioned
medium and then transplanted onto hippocampal slice
cultures (Fig. 1A); ii) NPCs were transplanted either alone
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Fig. 1. Schematic representation of the transplantation
paradigm. (A) Transplantation of pre-differentiated
NPCs. NPCs (as neurospheres) were labeled with BrdU
under proliferative conditions for 48 hours. Then, these
cells were plated on dishes and incubated with MSC-
conditioned medium (MSC-CM) for 48 hours. After this
period, BrdU-labeled NPCs were transplanted (TX) onto
a hippocampal slice. (B) Co-transplantation of MSCs
and NPCs. BrdU-labeled NPCs were mixed 1:1 with
MSCs or with eGFP-expressing MSC (MIX) and
transplanted onto a hippocampal slice. As a control,
BrdU-labeled NPCs were transplanted alone (NPCs).
Fig. 2. Presence and survival of transplanted NPCs
and MSCs on hippocampal slice cultures. (A)
Fluorescence image of GFP-expressing MSCs. MSCs
were co-transplanted with NPCs and incubated for 7
days. Note that GFP-expressing MSCs were found in
small clusters and in some cases as isolated cells. Scale
bar = 50 mm. (B) Confocal image of transplanted MSC.
GFP in green and the microglial marker Iba1 in red. Cell
nuclei are illustrated by TOPRO-3 (blue). GFP positive
and Iba1 positive cells do not co-localize. Scale bar = 50
ìm. (C, D) Fluorescence images of BrdU-labeled NPCs.
NPCs were transplanted alone (C) or co-transplanted
together with MSCs (D) onto hippocampal slice cultures
and incubated for 7 days. NPCs were detected in both
conditions. Upper right panels show an inset of
transplanted BrdU-labeled NPCs. Scale bar = 500 mm.
(E) Quantitative analysis of survival of BrdU-labeled
NPCs expressed as the number of transplanted cells
detected with respect to the total number of transplanted
cells. NPCs were transplanted alone (Control) or co-
transplanted together with MSCs (+ MSCs). Note that
in both conditions more than 40 % of the cells survived
after transplantation; there was no significant difference
between the two conditions (p > 0.05). Graph shows
means +/- SD and statistical analysis was performed
using non-parametrical one-tailed Mann Whitney t test.
(F) Confocal image of transplanted NPCs (BrdU labeling
in red) co-stained for active caspase-3 (green). BrdU/
active caspase-3 double positive cells were detected,
suggesting that at least some of the NPCs undergo cell
death by an apoptotic pathway. Scale bar = 50 µm.
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or together with MSCs onto hippocampal slice cultures
(Fig. 1B).
Limited survival of oligodendroglial
pre-differentiated NPCs after transplantation
In our previous study, we demonstrated that a two
to three day stimulation of NPCs with MSC-conditioned
medium (MSC-CM) was sufficient to trigger an
oligodendrogenic program in NPCs [8, 9]. NPCs
responded with elevated expression of the
oligodendrogenic determinants Olig1, Olig2 and Nkx2.2
and with reduced levels of the anti-oligodendrogenic
factor Id2, with induction of GalC and MBP expression
and inhibition of GFAP expression [8, 9]. To investigate if
NPCs that were pre-differentiated towards the
oligodendroglial lineage could survive and integrate into a
host CNS environment, we exposed BrdU labeled
NPCs to MSC-CM for two days prior to transplantation
on hippocampal slices. Seven days after grafting, we
were unable to detect any remaining BrdU-labeled
NPCs, suggesting that survival of oligodendroglial
pre-differentiated NPCs after transplantation was
limited.
MSCs promote oligodendroglial differentiation
of NPCs in hippocampal slices
Prior to transplantation, NPCs were labeled with
BrdU, which allows the analysis of cell survival and fate.
Typically, this procedure labels approximately 95%
of exposed NPCs. MSCs were genetically labeled to
express eGFP using a lentiviral construct. NPCs were
transplanted onto different regions of hippocampal slice
cultures either alone or in combination with MSCs.
One week later, the slices were analyzed for survival of
transplanted cells, as well as for differentiation, in the
case of transplanted NPCs.
Fig. 3. MSCs promote an oligodendroglial
fate of transplanted NPCs on hippocampal
slices. (A-I) Confocal images of transplanted
NPCs alone (A, D, G, H) or together with
MSCs (B, C, E, F, I) in hippocampal slice
cultures 7 days after transplantation.
To detect the final fate of transplanted NPCs,
cultures were processed for immuno-
histochemistry for BrdU (red, A-I) and for
different glial markers: 1) MBP (green, A-C),
GST-p (green, D-F) for oligodendrocytes and
2) GFAP (green, G-I) for astrocytes. Middle
column (B, E, H) shows a higher
magnification image including the Z-axis (C,
F and G, respectively). Scale bar = 50 mm.
Note the co-localization of BrdU signal with
the respective glial marker. (J-L) Quantitative
analysis of the fate of transplanted NPCs.
Graphs show the percentage of MBP- (J),
GST-p- (K) and GFAP- (L) expressing cells.
Note that MSCs enhance the percentage of
MBP- and GST-p- expressing cells
(oligodendrocytes) as an expense of GFAP-
expressing cells (astrocytes). Experiments
were done in triplicate. Results are expressed
as mean +/- SD and statistical analysis was
performed using non-parametrical one-tailed
Mann Whitney t test, (*), p < 0.05.
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MSCs were found to be present in the slice 7 days
after transplantation indicating that a significant number
of MSCs have survived on/in the slice. The cells were
not evenly distributed but appeared in clusters suggesting
that they did not disperse uniformly in/on the slice (Fig. 2
A). In addition, MSCs were predominantly detected at
the slice surface, only very few migrated deeper into the
tissue. Due to the lineage relation of MSCs with
macrophages/microglia, we analyzed the transplanted
MSCs for the presence of the microglia markers Iba1.
Confocal analysis revealed that none of the MSCs was
found to express Iba1, indicating that MSCs did not
differentiate into microglia under this condition (Fig. 2
B).
NPCs, as indicated by the BrdU label, were primarily
found in the CA3 region of the hippocampal slice, while
some cells were detected also in CA1 and in the dentate
gyrus (Fig. 2 C, D). Quantitative analysis of BrdU labeled
cells indicated that almost 50% of the transplanted NPCs
survived regardless of whether the cells had been
transplanted alone or together with MSCs (Fig. 2 E).
Active caspase-3 labeling of the BrdU-positive cells
suggests that some of the transplanted NPCs underwent
apoptosis (Fig. 2 F). Apoptotic and surviving transplanted
NPCs co-localized within the same regions, suggesting
that there were no regional hot-spots of cell death or
survival.
Next, we analyzed the fate of grafted NPCs.
Confocal analysis was used to identify and to quantify
the percentage of BrdU-positive cells, which co-labeled
either with MBP or GST-pi as markers for
oligodendrocytes, MBP is an important component of
myelin sheath [15] and it has been used as a marker
particular for mature oligodendrocytes [16], or with GFAP
as marker for astrocytes. When NPCs where transplanted
alone, most of the NPCs differentiated into GFAP
expressing cells (Fig. 3 L), and only a minor population
expressed MBP (Fig. 3 J). In contrast, NPC/MSC co-
transplantations generated predominantly cells expressing
the oligodendroglial markers MBP and GST-pi (Fig. 3 J
and K), while less cells were found to be GFAP-
immunoreactive (Fig. 3 L). Neuronal fate of transplanted
NPCs was analyzed using the young immature neuronal
marker DCX. We could not detect BrdU-labeled cells
that co-expressed DCX in any of the transplantation
paradigms, suggesting that neuronal differentiation of
transplanted NPCs in/on the hippocampal slice was
absent. In addition, none of the MSCs (GFP-positive cells)
was found to express GFAP, MBP or DCX, indicating
that MSCs do not differentiate into astroytes,
oligodendrocytes or neurons under this condition.
Discussion
The present report substantiates our previous finding
that MSCs provide a source of potent factors promoting
oligodendroglial fate, differentiation and maturation of
adult rodent NPCs [8, 9]. While NPCs alone
differentiated predominantly into astrocytes after being
transplanted on hippocampal slices, the co-transplantation
of NPCs together with MSCs favored oligodendrogenesis
of the transplanted NPCs. Thus, MSCs provide a pro-
oligodendrogenic microenvironment for transplanted
NPCs.
The underlying mechanisms and the molecules
involved in the MSC-oligodendrogenic activity are
currently unknown. However, we could recently exclude
transforming growth factor-beta1, sonic hedgehog, noggin,
fibroblast growth factor, vascular endothelial growth
factor, epithermal growth factor, ciliary neurotrophic
factor, brain derived neurotrophic factor, neurotrophin-3,
interleukin-6, thyroid hormone, and the signaling molecules
leukotrienes and UDP-glucose as potential candidates for
the MSCs-derived oligodendrogenic activity [8, 9]. The
identification of the molecular nature of the MSC-derived
oligodendrogenic activity could be crucial for the
development of molecular therapies. In the meantime,
the intraparenchymal or intracerebroventricular infusion
of non-fractionated MSC-conditioned medium had been
considered as an alternative strategy. However, a recent
study demonstrated that MSC-derived conditioned
medium had a toxic effect on hippocampal neurons [17],
thus confuting the feasibility such an approach.
A cellular approach via the ex vivo generation and
transplantation of pre-mature oligodendrocytes seems to
be a reasonable alternative to a molecular therapy.
However, the optimal cell type for such intervention is
still a matter of debate. In the present work, NPCs that
were pre-differentiated towards oligodendrocytes (pre-
mature) failed to survive grafting procedures and/or failed
to integrate into the host tissue. This is consistent with
previous studies, in which post-mitotic oligodendrocytes
as well as oligodendrocyte-precursor cells (OPCs) have
been used to promote remyelination in rodent models of
focal CNS demyelination. Oligodendrocytes were rather
ineffective in remyelination of chemically-induced de-
myelinated areas [18-20], whereas OPCs provided some
cellular repair [20-22]. Similarly, transplantation of adult
human OPCs into newborn shiverer mice resulted in
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